Access at: www.ICRjournal.com Percutaneous coronary intervention (PCI) is the most commonly used revascularisation modality for obstructive coronary artery disease. Vigorous advancement of drug-eluting stents (DES) across heavily calcified lesions also poses a risk of damage to the drug coating.
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Principles
RA ablates calcified plaque using a diamond-encrusted elliptical burr, rotated at speeds of 140,000 to 180,000 rpm by a helical driveshaft, that is advanced across the lesion over a guidewire ( Figure 1) . The burr causes 'differential cutting' and preferentially ablates hard, inelastic, calcified plaque that is unable to stretch away from the RA burr compared with healthy arterial tissue ( Figure 2) . 5 In contrast with balloon angioplasty, which produces intimal and medial dissections in calcified lesions, RA leads to lesser tissue injury and yields relatively smoother luminal surfaces and cylindrical geometry ( Figure 3 ). [23] [24] [25] The emphasis of the use of RA has shifted over the years from plaque debulking to plaque modification to facilitate balloon angioplasty and stent expansion. The transition in the approach has been driven by the results of the Study to Determine Rotablator and Transluminal
Angioplasty Strategy (STRATAS) and Coronary Angioplasty and
Rotablator Atherectomy Trial (CARAT) clinical trials. These trials showed that an aggressive strategy with large burrs (burr/artery ratio >0.7) to achieve maximum debulking as a lesion debulking strategy was associated with higher rates of angiographic complications, TLR and peri-procedural creatine kinase-myocardial band (CK-MB)
release compared with use of smaller burrs (burr/artery ratio ≤0.7) to modify lesion compliance with a lesion modification strategy without any clinical advantages in terms of procedural success or gain in luminal diameter. 26, 27 This change in approach has allowed the use of smaller burrs, guide catheters and sheaths without compromising clinical efficacy.
Indications and Clinical Outcomes
Indications
The principal indication for RA is modification of severely calcified de novo coronary stenoses which are unlikely to expand adequately with balloon angioplasty to allow for complete stent expansion.
The detection of severe coronary calcification traditionally relied on fluoroscopy but it has been demonstrated that fluoroscopy is less sensitive in calcium detection compared with intravascular imaging. 28 Severe coronary calcification on fluoroscopy has been described as radio-opacities noted without cardiac motion before contrast injection involving both sides of the arterial wall. 29 With intravascular ultrasound, severe calcification, indicated by bright echodensity causing attenuation of deeper structures, is defined as a large arc of superficial calcium involving ≥3 quadrants. 28 On optical coherence tomography (OCT), areas of coronary calcification appear well demarcated and signal-poor. OCT measures of coronary calcification predictive of stent underexpansion include: length >5 mm; arc >180°; and maximum thickness >0.5 mm. [30] [31] [32] RA can be used as a primary strategy in the presence of severe calcification or as a secondary approach after failure to dilate a lesion with coronary angioplasty. Although long-term outcomes are similar with planned versus bailout RA, planned RA is associated with lower procedure and fluoroscopy time, lower contrast volume and fewer in-hospital MACE. 33 Therefore, if there is a strong preprocedural likelihood of the use of RA in severely calcified lesions, operators should have a low threshold for adopting a planned RA strategy. In addition, although rarely an issue, there is concern about performing RA in a lesion that has undergone aggressive balloon angioplasty because of possible unrecognised intimal dissection.
Specific Lesion Subsets
There are certain lesion-specific considerations when using RA. RA provides an effective treatment option in patients with calcified unprotected left main (ULM) disease who are not eligible for CABG. In a report of 40 patients undergoing ULM RA, there was one procedural death and 12 deaths at 2-year follow-up. 34 In the ROTATE registry, although there were no differences in rates of in-hospital MACE 84 Reproduced with permission from Elsevier. 42 Other reports have also reported favourable results with drug-coated balloon angioplasty following RA for severe ISR. 43 Nonetheless, stent ablation with RA should be used with extreme caution by highly experienced operators, ideally with on-site surgical backup.
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Clinical Evidence
In the balloon angioplasty era, studies showed rates of restenosis with RA of approximately 40%, which is similar to using balloon angioplasty alone. 20, 21 During the bare-metal stent era, although RA use in calcified lesions before stenting was associated with higher procedural success with a trend towards lower restenosis rates, the absolute restenosis rates ranged between 20% and 30%. 6 With the advent of DES, neointimal proliferation was significantly inhibited and the rates of restenosis and TLR were reduced in general. 44, 45 Several studies have reported favourable intermediate and long-term outcomes with adjunctive RA before DES implantation with TLR rates of <10% at 1-to 2-year follow-up. [46] [47] [48] [49] [50] [51] It is, however, unclear whether adjunctive RA in calcified lesions before Source: Barbato et al. 2017 . 3 Reproduced with permission from Europa Digital & Publishing. A pecking motion of the RA burr -a quick-push forward/pull-back movement -is the most widely recommended motion pattern. The following predictors of procedural complications have been described: deceleration during rotablation >5,000 rpm; motion pattern of the burr; speed of rotablation; duration of individual runs. 56 The pecking motion minimises the decelerations of the RA burr and shortens the duration of individual runs (recommended <30 seconds). A recent Japanese study of 300 lesions treated with RA reported that 97 had moderate (5,000-10,000 rpm) and 21 had severe (>10,000 rpm) speed reduction. An ostial RCA lesion and total ablation time were found to be independent predictors of moderate speed reduction and an ostial RCA lesion, use of intra-aortic balloon pump, and higher systolic blood pressure before RA were predictors of a severe speed reduction. 57 The ideal rotablation speed is recommended to be about 140,000 to 180,000 rpm with lower 
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speeds being associated with burr entrapment and higher speeds linked to greater platelet activation. A recent study of 100 patients with calcified coronary artery disease randomised 1:1 to low-speed (140,000 rpm) or high-speed (190,000 rpm) RA showed no difference in incidence of slow flow (24% in both groups) or periprocedural MI (6% in both groups), suggesting that high-speed RA can be used safely with an appropriate technique when needed. 58 Visual, tactile and auditory feedback provide signals of resistance to burr advancement.
Once the lesion has been fully crossed, a final polishing run should be done, which should be able to be performed without resistance.
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Box 1 lists the key elements in optimal techniques of RA.
Pharmacology
Patients undergoing RA should receive antiplatelet and antithrombotic agents similar to standard PCI protocols. Glycoprotein IIb/IIIa that were previously shown to reduced periprocedural CK-MB release and slowflow phenomenon, are no longer recommended routinely but can be considered on a case-by-case basis.
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Flush Cocktail Cutting balloon use was an independent predictor of the presence of calcium fracture and greater stent expansion, suggesting that this might be a superior lesion preparation strategy following RA prior to stent implantation. 67 The presence of residual dogboning of angioplasty balloon at low-pressure inflation indicates inadequate plaque modification and merits consideration for a larger sized burr.
Contemporary DES are the standard treatment of choice following RA. 14, 22 Analysis of the multicentre ROTATE registry showed DES used to be associated with 68% reduction in follow-up MACE after RA. 68 
New Iteration
In 2018, Boston Scientific launched a new generation of the Rotablator system, called the ROTAPRO, aimed at simplifying the use of RA technology. 69 The foot pedal has been eliminated and replaced with a button on the top of the burr control knob, similar to the current orbital atherectomy device. The Dynaglide pedal has also been replaced by a button on the side of the advancer. The assembly is easier, more streamlined, with a new digitised display with deceleration indicators on the control console. Table 2 summarises the most common complications of RA and management strategies and Table 3 reports the reported complications rates of RA in the DES era. 
Complications of Rotational Atherectomy
Slow-flow/no-reflow results from microvascular embolisation of atherosclerotic debris and thrombi, platelet activation and vasoactive mediators and it is associated with periprocedural MI. 70 It has been hypothesised that microcavitations created by the rotating RA burr across the lesion also contribute to slow flow/no reflow. This transient microcavitation phenomenon has been demonstrated in vivo by enhanced myocardial echo contrast effect and directly correlates with rotablation speed, burr size and duration. 71, 72 The incidence of this complication is up to about 2.5% in contemporary reports. 11, [46] [47] [48] [49] [50] [51] 68, 73 Technical factors contributing to this complication include use of larger burrs, longer runs and sudden decelerations. 22 Optimal technique, 
Dissection and Perforation
The incidence of coronary dissection with RA varies from 1.7% to 5.9%
in the DES era. 5, 47, 74 Once a severe dissection is identified, RA should be stopped, and focus should be on maintaining wire position in true lumen and completion of PCI with balloon angioplasty and stenting. If the antegrade flow is preserved, the procedure could be stopped, and the procedure reattempted in 3-4 weeks after the dissection heals. 22 Coronary perforation due to rotablation is rare with reported incidence of up to 2% and it is usually related to poor technique with oversizing or forceful advancement of burr. It must, however, be noted that coronary perforation rates with PCI with RA are higher than PCI 
Burr Entrapment
Burr lodging within a lesion is a serious complication of RA that might require surgical intervention. 78 Once stalled within a lesion, retrograde ablation is not possible because of the presence of diamond chips on the front but not the rear of the RA burr. This complication is more common with the 1.25 mm burr due to its fusiform shape which can result in sudden forward movement if the tension in the system was not removed before starting RA. Careful, conservative technique with small burr sizes, short duration of runs, short segment ablation and the pecking motion are crucial in preventing burr entrapment.
Percutaneous salvage options include: pulling the RA wire using its 0.014 inch spring tip combined with push and pull on the drive shaft; balloon dilation proximal to the entrapped burr via same or different guide catheter from a different access site; deep intubation of guiding catheter or cutting the burr drive shaft with insertion of a mother-in-child catheter; and subintimal tracking and re-entry with balloon dilatation adjacent to the trapped burr. 14, [79] [80] [81] If retrieval is unsuccessful with the above catheter-based techniques, a cardiac surgery consultation will be necessary.
Clinical Predictors of Rotational Atherectomy Complications
Optimal RA techniques, as described above, are key to prevent periprocedural complications. A multicentre UK study identified peripheral vascular disease, diabetes, presentation with acute coronary syndromes and higher SYNTAX score to be predictors of major adverse cardiovascular events following RA. 82 Similarly, a report from the Japanese PCI (J-PCI) registry of 13,335 RA cases identified older age, impaired kidney function, previous MI, emergent PCI, triple-vessel disease and lower institutional RA volume as independent predictors of worse periprocedural outcomes after RA. 
